COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.06
+0.03 (+2.91%)
Open$1.06
Previous Close$1.03
Day High$1.09
Day Low$0.97
52W High$2.67
52W Low$0.76
Volume—
Avg Volume84.7K
Market Cap14.85M
P/E Ratio—
EPS$-0.73
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,534.0% upside
Current
$1.06
$1.06
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.74M | 2.80M | 3.00M |
| Net Income | 504.5K | 668.5K | 544.9K |
| Profit Margin | 18.4% | 23.9% | 18.1% |
| EBITDA | 921.2K | 997.7K | 969.2K |
| Free Cash Flow | 728.8K | 746.2K | 561.0K |
| Rev Growth | +19.3% | -9.2% | +14.0% |
| Debt/Equity | 0.92 | 0.92 | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |